Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer [Phase 2]
Phase 2 clinical study evaluating enzalutamide alone, enzalutamide with mifepristone, or chemotherapy in people with metastatic breast cance…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Video Education With Result Dependent dIsclosure [NA]
A Dana-Farber Cancer Institute clinical trial update for a study on video education with result-dependent disclosure, currently recruiting, …
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications
A clinical trial at MD Anderson Cancer Center is evaluating contrast-enhanced mammography to assess mammographic microcalcifications in brea…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer
This entry announces an ongoing Mayo Clinic clinical trial collecting specimens and clinical data from patients with recurrent or metastatic…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer [Phase 3]
A Phase 3 clinical trial evaluating IBI-354 with or without pertuzumab versus a standard regimen of taxane, trastuzumab and pertuzumab in HE…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating ZN-A-1041 enteric capsules alone or in combination for HER2-positive advanced solid tumors, including HER2-positi…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Navigation Intervention for Adolescent and Young Adult Cancer Survivors [NA]
A Kaiser Permanente-sponsored clinical trial update describes a navigation intervention for adolescent and young adult cancer survivors. The…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Comparison of Mastectomy Expander Trial [NA]
The clinical trial update indicates a not-yet-recruiting study comparing mastectomy expander-based reconstruction options in breast cancer p…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Safe and Explainable AI
A recruiting clinical trial is reported, led by the Abramson Cancer Center at Penn Medicine, investigating safe and explainable artificial i…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Adding Magnesium Sulfate to Combined Pecto-Intercostal & Serratus Anterior Planes Block on Post-operative Analgesia in Patients Undergoing Modified Radical Mastectomy [NA]
This clinical trial update investigates whether adding magnesium sulfate to a combined pecto-intercostal and serratus anterior plane block i…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer [Phase 1]
This clinical trial update announces the first-in-human, Phase 1 study of ATX-295, an oral inhibitor of KIF18A, in patients with advanced or…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer
AstraZeneca is conducting a clinical trial to evaluate an AI-based screening tool that predicts genetic risk for breast cancer, and the stud…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Prospective Ultrasound Data Collection Study for AI-Based Detection of Breast Biopsy Markers
This clinical trial is a prospective ultrasound data collection study to evaluate AI-based detection of breast biopsy markers. It is sponsor…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating the safety and tolerability of TransCon IL-2 β/γ alone or in combination w…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Prehabilitation in Breast Cancer Surgery [NA]
Clinical trial evaluating prehabilitation strategies in early breast cancer patients undergoing surgery. The study status is not yet recruit…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer [NA]
A clinical trial update describes assessing adherence to remotely monitored physical activity via a smartwatch and its potential to reduce f…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Evaluation of the Impact of Pre-habilitation Using Physiotherapy and Mechanical Stimulation on Shoulder Pain and Mobility in Patients Undergoing Breast Reconstruction Using a Latissimus Dorsi Flap [NA]
This clinical trial aims to assess whether prehabilitation using physiotherapy and mechanical stimulation improves shoulder pain and mobilit…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Pre-Operative Window of ET to Inform RT Decisions (POWER II) [Phase 3]
A Phase 3 trial (POWER II) sponsored by the University of Virginia is testing a pre-operative window of endocrine therapy to guide radiother…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Acceptability and Feasibility of PSC Model of Serious Illness Communication [NA]
A National Cancer Centre, Singapore study evaluates the acceptability and feasibility of a PSC (patient-serious illness communication) model…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Axillary Lymph Node Changes After Neoadjuvant Therapy In Breast Cancer [NA]
Clinical trial update on axillary lymph node changes after neoadjuvant therapy in breast cancer. The study is sponsored by the Institute of …
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients [NA]
A clinical trial evaluating a web-based application to monitor radiation therapy-related complications in cancer patients, currently recruit…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer [Phase 2]
Phase 2 study evaluating tucatinib in combination with trastuzumab for patients with HER3-mutant and HER2-non-amplified metastatic or unrese…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer [NA]
A Johns Hopkins University clinical trial is examining whether treating insomnia influences behavioral weight loss outcomes in breast cancer…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer [Phase 3]
A Phase 3 trial is evaluating Trastuzumab deruxtecan (T-DXd) alone or in sequence with THP versus standard ddAC-THP in HER2-positive early b…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Interview of Patients With HR+/HER2- Metastatic Breast Cancer Who Received Capivasertib + Fulvestrant
This document summarizes an interview-based update from a completed trial of capivasertib plus fulvestrant in HR+/HER2- metastatic breast ca…